Ultragenyx Pharmaceutical (RARE) has announced a transaction involving the sale of an additional 25% of its royalty interest ...

Cancer screening and diagnostics specialist Exact Sciences (NASDAQ: EXAS) was a standout stock on the second trading day of the week. Eager investors piled into it to leave it with a nearly 4% gain in ...

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost ...

The Origins Federation Conference gathered researchers across disciplines in the search for how life began on Earth—and maybe elsewhere ...

Harvard’s Faculty of Arts and Sciences is running an estimated structural deficit of approximately $350 million, a major ...

Wisconsin-based Exact Sciences won't move forward on a 250,000 square-foot cancer detection facility in Phoenix.

Blackstone Life Sciences agreed to give Merck $700 million to support its development of an investigational cancer drug called sacituzumab tirumotecan in exchange for low-to-mid-single-digit royalties ...

Johnson & Johnson’s medical technology unit and its health data company Verily have penned separate new deals with technology ...

STARKVILLE, Miss.—Adding to her growing list of accomplishments, Mississippi State University Associate Professor Amy Dapper ...

The company says it’s identified new metals that can be used to make clean hydrogen fuel from water at low cost.

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A ...

The 37th annual Health Sciences Research Day was hosted by Marshall University’s Joan C. Edwards School of Medicine ...